There Are Cancers, and Then There is Cancer
Last week, in the face of a cancer that threatens the Ukraine, Europe and Western civilization, I wrote that words fail. Unfortunately, my worst fears have been realized thus far. I believe that Putin will not stop unless he is stopped, somehow, some way. Only when cancers of the human spirit have been suppressed will the Ukraine have a chance to worry about cancers of the body.
|
|
Monday, March 21 - Friday, March 25
Afternoons in The Research Building
In-person and hybrid/virtual format, by appointment
|
|
Personnel from the Office of Faculty and Academic Affairs will conduct a workshop on Wednesday, March 16, from 4:30 - 5:30 p.m. about the appointment and promotion process and faculty development resources available on the research track. Contact ofaa@georgetown.edu with questions. Register for this workshop.
|
|
Tuesday, March 8
12:00 - 1:00 p.m.
Haiyan He, PhD, assistant professor in the Department of Biology at Georgetown University and a GHUCCTS KL2 scholar, presents “Too Many NEW Cooks Spoil the Broth? A Novel Nascent Protein-Degradation-Based Mechanism for Fast Homeostatic Control of Neuronal Activity.” Register for this Zoom event.
|
|
CDI Seminar Virtual Presentation
Tuesday, March 8
3:00 - 4:00 p.m.
Binfeng Lu, PhD, professor, Department of Immunology at University of Pittsburgh School of Medicine, member, University of Pittsburgh Cancer Institute, presents “Tissue Alarmin Cytokines as a Novel Cancer Immunotherapy.” Join this seminar via Zoom.
|
|
Thursday, March 10
9:00 - 10:00 a.m.
|
|
Thursday, March 10
4:00 - 5:00 p.m.
M. Celeste Simon, PhD, scientific director and investigator, Abramson Family Cancer Research Institute; associate director, Shared Resources, Abramson Cancer Center; Arthur H. Rubenstein, MBBCh Professor, Department of Cell and Developmental Biology, University of Pennsylvania Perelman School of Medicine, presents “Exploiting Metabolic Tumor ‘Neighborhoods.’” Sponsored by the Office of the Dean for Research. Join the Dean’s Seminar via Zoom.
|
|
Friday, March 11
10:00 - 11:00 a.m.
Kimberly A. Miller, PhD, MPH, associate professor, Department of Population and Public Health Sciences and Department of Dermatology, Keck School of Medicine, University of Southern California, presents “The Power of Cancer Surveillance Data: Population-Based Research Among Diverse Young Adult Cancer Survivors in California.” Presented by the Survivorship Research Initiative. Join this seminar via Zoom.
|
|
Friday, March 11
12:00 - 1:00 p.m.
Daniel Belsky, PhD, Assistant Professor, Butler Columbia Aging Center and Department of Epidemiology, Columbia University Mailman School of Public Health, presents “Quantification of Biological Aging.” Join the lecture via Zoom.
|
|
Friday, March 11
12:00 - 1:00 p.m.
Moshe Levi, MD, interim dean for research, professor of biochemistry and molecular & cellular biology, presents “The Role of Nuclear Receptors in Regulation of Metabolism and Disease.” Co-sponsored by Georgetown and the Frederick National Laboratory for Cancer Research. Join this lecture via WebEx.
|
|
Tuesday, March 15
12:00 - 1:00 p.m.
Yama A. Abassi, PhD, vice president, ACEA Biosciences, presents “Crossing the Chasm: The Trials and Tribulations of Marketing and Commercializing Cutting Edge Biomedical Technologies.” Sponsored by the Office of Technology Commercialization. Register for this event.
|
|
Tuesday, March 15
12:00 - 1:00 p.m.
Subramaniam Pennathur, MD, professor of medicine and molecular and integrative physiology, University of Michigan, presents “Beyond Blood Sugar: Metabolic Basis of Diabetic Kidney Disease.” Sponsored by the Department of Biochemistry and Molecular & Cellular Biology. Join the Bhussry Seminar via Zoom.
|
|
Funding and Award Opportunities
Gilead and Kite Research Scholarships in Oncology
Gilead Sciences and Kite Research Scholars Programs support innovative research from early career investigators around the world to advance scientific knowledge in areas of unmet medical need and improve the lives of patients everywhere. The Research Scholars Program offerings in the fields of hematology and oncology are designed to support innovative basic, translational, and/or clinical research projects in hematologic malignancies and solid tumors. Each award is funded up to $130,000 for two years, to be paid in annual installments of up to $65,000 USD per year. Junior faculty and early career scientists from the United States and Canada are eligible to apply. Gilead and Kite currently offer two Research Scholars Programs in oncology:
_______________________________
Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program
The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (BMSF DCTCDP) is a two-year program designed to support the career development of early-stage investigator (as defined by NIH) physicians underrepresented in medicine, or physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring. Awardees receive $120K/year for two years; requires at least 40% of the scholar’s time. View more information. LOI deadline extended to March 15 at 11:59 p.m. ET.
_______________________________
MDS Research Fund
The Vera and Joseph Dresner Foundation founded the MDS Research Fund to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders. The foundation is now accepting Letters of Inquiry for its 6th annual MDS Research Fund. A total of three new grants, two Early Career Awards and one Established Investigator Award, will be awarded.
- Early Career Investigator Awards will provide funding of up to $125,000 per year for two years
- Established Investigator Awards will provide funding of up to $250,000 per year for two years.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | Fellows Meeting with Dr. Gramza | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 80737; phone: 202-796-7323)
12:15 PM | Dr. Tesfaye – Gastric Cancer | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom
9:00 AM | Thoracic Research Meeting – Thoracic Fellow | Podium A / Microsoft Teams
12:15 PM | Dr. Patel (NIH) – Bone Marrow Failures | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
5:00 PM | Breast Onc Candidate: Miriam T. Jacobs, MD, Oncology Fellow, Barnes-Jewish Hospital, Washington University School of Medicine | Zoom (dial 646-558-8656; Meeting ID: 94718106181)
|
|
9:00 AM | Cancer Research Data Meeting | Speaker: Alec McIntosh | Zoom
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | Dr. Gilstad – Hemostatic Effect of RBCs | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series: Daniel Belsky, PhD | “Quantification of Biological Aging” | Zoom
12:15 PM | No Lecture | Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
